Fundraising Fox
Portola Pharmaceuticals
acquired by Alexion6 known investors
Find your way into Portola Pharmaceuticals
Sign up to find every way you can get introduced to Portola Pharmaceuticals
- Your email: who you already know at Portola Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Portola Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Portola develops research and investigates new targets, modalities, and technologies to address rare disease challenges for patients and their families.
Investors · 6
How we know: Bluebird Ventures's portfolio page · Not right? Tell us
How we know: Frazier Life Sciences's portfolio page · Not right? Tell us
How we know: Lightstone Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Prospect Venture Partners's portfolio page · Not right? Tell us
How we know: funding news · startupecosystem.ca · Not right? Tell us
How we know: funding news · startupecosystem.ca · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJul 2025
Khosla Ventures (lead), NFDG
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
4 people who came through Portola Pharmaceuticals went on to found or lead other companies.
Frequently asked questions
- What does Portola Pharmaceuticals do?
- Portola develops research and investigates new targets, modalities, and technologies to address rare disease challenges for patients and their families.
- Who are Portola Pharmaceuticals's investors?
- Portola Pharmaceuticals's investors include Bluebird Ventures, Frazier Life Sciences, Lightstone Ventures, Prospect Venture Partners, Khosla Ventures, NFDG.
- Who acquired Portola Pharmaceuticals?
- Portola Pharmaceuticals was acquired by Alexion.